| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/19/1992 | CN1017897B Dihydropyridine derivatives, their preparation and their use |
| 08/18/1992 | US5140038 Thromboxane A2 antagonists |
| 08/18/1992 | CA1306583C Pasteurizable, freeze-driable hemoglobin-based blood substitute |
| 08/18/1992 | CA1306581C Platelet binding inhibitors |
| 08/13/1992 | WO1992014438A2 Prostacycline and carbacycline derivatives as agents for treating feverish complaints |
| 08/13/1992 | WO1992013847A1 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds |
| 08/13/1992 | DE4104607A1 Prostacyclin- und carbacyclinderivate als mittel zur behandlung von fiebrigen erkrankungen Prostacyclin and carbacyclin as a medium for treatment of febrile diseases |
| 08/13/1992 | DE4103649A1 Neue antikoagulatorisch wirksame peptide New anticoagulatory peptide |
| 08/13/1992 | CA2104024A1 Prostacyclin and carbacylin derivatives as agents for treatment of febrile diseases |
| 08/13/1992 | CA2100160A1 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds |
| 08/12/1992 | EP0498508A1 Factor IIa inhibitors |
| 08/12/1992 | EP0498470A2 An injectable pharmaceutical composition for the protection of tissue damaged by ischemia |
| 08/12/1992 | EP0498334A1 2,4- and 2,5-bis-(tetrazolyl)pyridines, process for their preparation and their use as medicines |
| 08/12/1992 | EP0497756A1 Antithrombotic composition. |
| 08/12/1992 | CA2060940A1 N-imidazolyl derivatives of substituted alkoxyimino tetrahydro-naphthalenes and chromans |
| 08/11/1992 | US5138035 Enzyme inhibitors |
| 08/11/1992 | US5137914 Vasodilation, anticoagulants, bronchodilator agents |
| 08/11/1992 | US5137911 Isochromane derivatives |
| 08/11/1992 | US5137885 Inotropic agents; vasodilators |
| 08/10/1992 | CA2060954A1 Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs |
| 08/06/1992 | WO1992013075A1 Megakaryocyte stimulating factors |
| 08/06/1992 | WO1992012734A1 Anti-growth factor antibodies in the treatment of vascular stenosis |
| 08/06/1992 | CA2060622A1 2,4- and 2,5-bistetrazolylpyridines, a process for the preparation thereof and the use thereof as pharmaceuticals |
| 08/05/1992 | WO1992013877A1 Factor iia inhibitors |
| 08/05/1992 | EP0497695A1 N-2-chlorobenzyl-2-oxo and N-2-chlorobenzyl-2,2-dioxo-1,2,3-oxathiazolidine derivatives, their preparation and synthesis of thieno[3,2-c]pyridine derivatives therefrom |
| 08/05/1992 | EP0497629A1 Heterocyclic amido prostaglandin analogs |
| 08/05/1992 | EP0497234A2 Phosphatidylinositol analogues, inhibitors of phosphatidyl-inositol-specific phospholipase C |
| 08/05/1992 | EP0497162A1 Pharmaceutical compositions containing orally absorbable glycosaminoglycans |
| 08/05/1992 | EP0497122A1 Substituted 3-aminosydnonimines, process for their preparation and their use |
| 08/05/1992 | EP0497085A1 Heterocyclic ketone prostaglandin analogs |
| 08/05/1992 | EP0496833A1 BIOSYNTHETIC CONSTRUCTS OF TGF-$g(b) |
| 08/05/1992 | EP0496753A1 2-bicyclo-benzimidazoles, process for their production and drugs containing said compounds |
| 08/05/1992 | EP0261185B1 7-oxoprostacycline derivatives and process for their manufacture |
| 08/05/1992 | CA2101331A1 Factor iia inhibitors |
| 08/04/1992 | US5135949 Pharmaceutical compositions containing phenylamides |
| 08/04/1992 | US5135939 Treating thermobotic and vasospastic disease |
| 08/02/1992 | CA2060083A1 Phosphatidylinositol analogues, inhibitors of phosphatidylinositol-specific phospholipase c |
| 08/02/1992 | CA2059906A1 Heterocyclic amido prostaglandin analogs |
| 07/30/1992 | WO1992012708A1 Anti-coagulant properties of macrocyclic compounds and method of treatment |
| 07/30/1992 | CA2100676A1 Anti-coagulant properties of macrocyclic compounds and method of treatment |
| 07/29/1992 | EP0496725A2 Complex containing coagulation factor IX |
| 07/29/1992 | EP0496327A1 Polypeptides with prourokinase activity, plasmids coding therefor and process for their preparation and use |
| 07/29/1992 | EP0496237A2 N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept[b]indole |
| 07/29/1992 | CA2057546A1 Heterocyclic ketone prostaglandin analogs |
| 07/28/1992 | US5134151 Platelet Activating Factor Antagonist |
| 07/28/1992 | US5134149 Serotonin antagonist |
| 07/28/1992 | CA1305713C (d) and (l)-3-(amino-methyl)-2-methanol-7-oxabicyclo¬2.2.1| heptane |
| 07/28/1992 | CA1305710C Process for preparing a 2,3-dihydro-1h-imidazolylethoxyindene derivative and its pharmaceutically acceptable salts |
| 07/27/1992 | CA2060030A1 Substituted 3-aminosydnone imines, process for the preparation therefore and the use thereof |
| 07/23/1992 | WO1992012119A1 The effect of n,n,n-trimethylsphingosine on protein kinase-c activity; melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregation |
| 07/23/1992 | WO1992008792A3 Method for increasing and activating monocytes and neutrophils and for inducing maturation of myeloid cells with interleukin-5 |
| 07/23/1992 | CA2097324A1 Effect of n,n,n-trimethylsphingosine on protein kinase-c activity; melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregation |
| 07/23/1992 | CA2059741A1 N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept¬b|indole |
| 07/22/1992 | EP0495473A1 New diazepines substituted in position 6, process for their production and their use as drugs |
| 07/22/1992 | EP0495047A1 Stable hemoglobin based composition and method to store same. |
| 07/22/1992 | CN1017527B Process for preparing optically active oxo-isoindolinyl derivatives |
| 07/21/1992 | US5132435 2-thienylglycidic derivative, process for its preparation and its use as synthesis intermediate |
| 07/21/1992 | US5132298 Diuresis by cyclodextrins and their derivatives |
| 07/21/1992 | CA1305413C Process for producing a coagulation active complex of factor viii fragments |
| 07/18/1992 | CA2100876A1 Anti-growth factor antibodies in the treatment of vascular stenosis |
| 07/17/1992 | CA2059353A1 Diazepines substituted in the 6-position, processes for their preparation and their preparation and their use as pharmaceutical compositions |
| 07/15/1992 | WO1992012128A1 (amidomethyl)nitrogen heterocyclic analgesics |
| 07/15/1992 | EP0494702A2 Production of factor XIIIa by gene technology |
| 07/15/1992 | EP0494248A1 Anti-thrombotic peptides and pseudopeptides |
| 07/15/1992 | EP0378549B1 Pharmaceutical composition for preventing and treating bacterial or viral diseases |
| 07/15/1992 | EP0162067B1 Production of factor viii and related products |
| 07/15/1992 | CA2100551A1 (amidomethyl) nitrogen heterocyclic analgesics |
| 07/14/1992 | US5130329 Benzocyclohexanes and benzocycloheptanes useful as analgesics |
| 07/14/1992 | US5130245 Insert containing dna coding system; treatment of diseases causes by superoxide radicals |
| 07/14/1992 | US5130061 Ester interchange and dilution with ethanol |
| 07/14/1992 | CA1305059C Stabilized menadione bisulfite formulations and their preparation |
| 07/09/1992 | WO1992011383A1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF$g(a) |
| 07/09/1992 | WO1992011283A1 Transgenic, cross-linked hemoglobin |
| 07/09/1992 | WO1992011265A1 OXO-TETRAHYDROPYRIDAZINYL-PYRAZOLO[4,3-b]-1,4-BENZOXAZINES |
| 07/09/1992 | WO1992011235A1 N-(mercaptoalkyl)amides |
| 07/09/1992 | WO1992011010A1 New 3,4-dihydroisoquinoline derivates and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines |
| 07/09/1992 | CA2098917A1 New 3,4-dihydroisoquinoline derivatives and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines |
| 07/09/1992 | CA2098818A1 Transgenic, cross-linked hemoglobin |
| 07/08/1992 | EP0493588A1 Analogs of hirudin |
| 07/08/1992 | EP0493506A1 Chimeric amino acids and peptides containing these analogues |
| 07/08/1992 | EP0493494A1 New proteins suitable for combating disease and for protecting grazing cattle from ticks |
| 07/08/1992 | EP0493380A1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs. |
| 07/08/1992 | CN1062537A Heparin derivatives |
| 07/07/1992 | US5128450 Bone marrow |
| 07/07/1992 | US5128351 Bis-aryl amide and urea antagonists of platelet activating factor |
| 07/07/1992 | US5128151 Stabilized menadione bisulfite formulations and their preparation |
| 07/01/1992 | EP0493324A1 Certain (arylsulfonamido- and pyridyl- or imidazolyl-)-substituted carboxylic acids and derivatives thereof |
| 07/01/1992 | EP0493037A2 Method of treating thromboembolic disorders |
| 07/01/1992 | EP0492257A1 Thiadiazinone derivatives |
| 07/01/1992 | EP0491755A1 Gamma glutamyl transferases for treating diseases |
| 06/30/1992 | US5126368 Octenoic acid derivatives useful as thromboxane A2 inhibitors |
| 06/30/1992 | US5126353 Compositions and method of treating arrythmia with tetrahydropyridines |
| 06/30/1992 | US5126325 Method for treating thrombocytopenia |
| 06/30/1992 | US5126134 Pharmaceutically active combination |
| 06/29/1992 | WO1992012177A1 Novel megakaryocyte amplifier and production thereof |
| 06/29/1992 | CA2073177A1 Megakaryocyte potentiator and method for producing the same |
| 06/27/1992 | CA2058384A1 Certain (arylsulfonamido- and pyridyl- or imidazolyl-) substituted carboxylic acids and derivatives thereof |
| 06/25/1992 | WO1992010755A1 Proteins with changed epitopes and methods for the production thereof |
| 06/25/1992 | WO1992010498A1 Novel csaids |
| 06/25/1992 | WO1992010097A1 Angiotensin ii receptor blocking compositions |